Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Association of changes in bone mineral parameters with mortality in haemodialysis patients: insights from the ARO cohort.

Lamina C, Kronenberg F, Stenvinkel P, Froissart M, Forer L, Schönherr S, Wheeler DC, Eckardt KU, Floege J.

Nephrol Dial Transplant. 2019 Apr 21. pii: gfz060. doi: 10.1093/ndt/gfz060. [Epub ahead of print]

PMID:
31006013
2.

Performance of creatinine-based equations for estimating glomerular filtration rate changes over time.

van Rijn MHC, Metzger M, Flamant M, Houillier P, Haymann JP, van den Brand JAJG, Froissart M, Stengel B; NephroTest Study Group.

Nephrol Dial Transplant. 2018 Sep 1. doi: 10.1093/ndt/gfy278. [Epub ahead of print]

PMID:
30184233
3.

Low perfusion pressure is associated with renal tubular injury in infants undergoing cardiac surgery with cardiopulmonary bypass: A secondary analysis of an observational study.

Bojan M, Basto Duarte MC, Lopez V, Tourneur L, Vicca S, Froissart M.

Eur J Anaesthesiol. 2018 Aug;35(8):581-587. doi: 10.1097/EJA.0000000000000782.

PMID:
29432378
4.

Association of a Low-Protein Diet With Slower Progression of CKD.

Metzger M, Yuan WL, Haymann JP, Flamant M, Houillier P, Thervet E, Boffa JJ, Vrtovsnik F, Froissart M, Bankir L, Fouque D, Stengel B.

Kidney Int Rep. 2017 Aug 30;3(1):105-114. doi: 10.1016/j.ekir.2017.08.010. eCollection 2018 Jan.

5.

Structural equation modelling exploration of the key pathophysiological processes involved in cardiac surgery-related acute kidney injury in infants.

Bojan M, Basto Duarte MC, Ermak N, Lopez-Lopez V, Mogenet A, Froissart M.

Crit Care. 2016 Jun 5;20(1):171. doi: 10.1186/s13054-016-1350-1.

6.

Development and validation of cardiovascular risk scores for haemodialysis patients.

Anker SD, Gillespie IA, Eckardt KU, Kronenberg F, Richards S, Drueke TB, Stenvinkel P, Pisoni RL, Robinson BM, Marcelli D, Froissart M, Floege J; On behalf the ARO Steering Committee (collaborators).

Int J Cardiol. 2016 Aug 1;216:68-77. doi: 10.1016/j.ijcard.2016.04.151. Epub 2016 Apr 20.

PMID:
27140339
7.

Anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism.

de Francisco AL, Gillespie IA, Gioni I, Floege J, Kronenberg F, Marcelli D, Wheeler DC, Froissart M, Drueke TB; ARO Steering Committee Cllaborators.

Nefrologia. 2016;36(2):164-75. doi: 10.1016/j.nefro.2015.10.006. Epub 2015 Dec 3.

8.

Inflammation Modifies the Paradoxical Association between Body Mass Index and Mortality in Hemodialysis Patients.

Stenvinkel P, Gillespie IA, Tunks J, Addison J, Kronenberg F, Drueke TB, Marcelli D, Schernthaner G, Eckardt KU, Floege J, Froissart M, Anker SD; ARO Steering Committee.

J Am Soc Nephrol. 2016 May;27(5):1479-86. doi: 10.1681/ASN.2015030252. Epub 2015 Nov 13.

9.

Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all-cause mortality.

Gillespie IA, Floege J, Gioni I, Drüeke TB, de Francisco AL, Anker SD, Kubo Y, Wheeler DC, Froissart M; on behalf the ARO Steering Committee collaborators.

Pharmacoepidemiol Drug Saf. 2015 Jul;24(7):738-47. doi: 10.1002/pds.3789. Epub 2015 May 26.

10.

High cardiovascular event rates occur within the first weeks of starting hemodialysis.

Eckardt KU, Gillespie IA, Kronenberg F, Richards S, Stenvinkel P, Anker SD, Wheeler DC, de Francisco AL, Marcelli D, Froissart M, Floege J; ARO Steering Committee.

Kidney Int. 2015 Nov;88(5):1117-25. doi: 10.1038/ki.2015.117. Epub 2015 Apr 29.

11.

Urinary creatinine excretion, measured glomerular filtration rate and CKD outcomes.

Tynkevich E, Flamant M, Haymann JP, Metzger M, Thervet E, Boffa JJ, Vrtovsnik F, Houillier P, Froissart M, Stengel B; NephroTest Study Group.

Nephrol Dial Transplant. 2015 Aug;30(8):1386-94. doi: 10.1093/ndt/gfv047. Epub 2015 Mar 27.

PMID:
25817225
12.

Urinary ammonia and long-term outcomes in chronic kidney disease.

Vallet M, Metzger M, Haymann JP, Flamant M, Gauci C, Thervet E, Boffa JJ, Vrtovsnik F, Froissart M, Stengel B, Houillier P; NephroTest Cohort Study group.

Kidney Int. 2015 Jul;88(1):137-45. doi: 10.1038/ki.2015.52. Epub 2015 Mar 11.

PMID:
25760321
13.

Contribution of lymphoscintigraphy to intraoperative sentinel lymph node detection in early cervical cancer: Analysis of the prospective multicenter SENTICOL cohort.

Bats AS, Frati A, Mathevet P, Orliaguet I, Querleu D, Zerdoud S, Leblanc E, Gauthier H, Uzan C, Deandreis D, Darai E, Kerrou K, Marret H, Lenain E, Froissart M, Lecuru F.

Gynecol Oncol. 2015 May;137(2):264-9. doi: 10.1016/j.ygyno.2015.02.018. Epub 2015 Feb 26.

PMID:
25727652
14.

Factors precipitating erythropoiesis-stimulating agent responsiveness in a European haemodialysis cohort: case-crossover study.

Gillespie IA, Macdougall IC, Richards S, Jones V, Marcelli D, Froissart M, Eckardt KU; ARO Steering Committee.

Pharmacoepidemiol Drug Saf. 2015 Apr;24(4):414-26. doi: 10.1002/pds.3755. Epub 2015 Feb 17.

15.

Development and validation of a predictive mortality risk score from a European hemodialysis cohort.

Floege J, Gillespie IA, Kronenberg F, Anker SD, Gioni I, Richards S, Pisoni RL, Robinson BM, Marcelli D, Froissart M, Eckardt KU.

Kidney Int. 2015 May;87(5):996-1008. doi: 10.1038/ki.2014.419. Epub 2015 Feb 4.

16.

Decrease in urinary creatinine excretion in early stage chronic kidney disease.

Tynkevich E, Flamant M, Haymann JP, Metzger M, Thervet E, Boffa JJ, Vrtovsnik F, Houillier P, Froissart M, Stengel B; NephroTest Study Group.

PLoS One. 2014 Nov 17;9(11):e111949. doi: 10.1371/journal.pone.0111949. eCollection 2014.

17.

Feasibility and performance of lymphoscintigraphy in sentinel lymph node biopsy for early cervical cancer: results of the prospective multicenter SENTICOL study.

Bats AS, Frati A, Froissart M, Orliaguet I, Querleu D, Zerdoud S, Leblanc E, Gauthier H, Uzan C, Deandreis D, Darai E, Kerrou K, Marret H, Lenain E, Mathevet P, Lecuru F.

Ann Nucl Med. 2015 Jan;29(1):63-70. doi: 10.1007/s12149-014-0910-1. Epub 2014 Nov 15.

18.

The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease.

Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Froissart M, Stengel B; NephroTest Study Group.

PLoS One. 2014 Jun 30;9(6):e99781. doi: 10.1371/journal.pone.0099781. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0123145. Mercadel, Lucile [corrected to Mercadal, Lucile].

19.

A 3-marker index improves the identification of iron disorders in CKD anaemia.

Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, Vrtovsnik F, Gauci C, Froissart M, Stengel B; NephroTest Study Group.

PLoS One. 2014 Feb 19;9(2):e84144. doi: 10.1371/journal.pone.0084144. eCollection 2014. Erratum in: PLoS One. 2014;9(6):e100606.

20.

Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test.

Fan L, Inker LA, Rossert J, Froissart M, Rossing P, Mauer M, Levey AS.

Nephrol Dial Transplant. 2014 Jun;29(6):1195-203. doi: 10.1093/ndt/gft509. Epub 2014 Jan 20.

21.

Renal function can improve at any stage of chronic kidney disease.

Weis L, Metzger M, Haymann JP, Thervet E, Flamant M, Vrtovsnik F, Gauci C, Houillier P, Froissart M, Letavernier E, Stengel B, Boffa JJ; NephroTest Study Group.

PLoS One. 2013 Dec 13;8(12):e81835. doi: 10.1371/journal.pone.0081835. eCollection 2013.

22.

Enzymatic creatinine assays allow estimation of glomerular filtration rate in stages 1 and 2 chronic kidney disease using CKD-EPI equation.

Kuster N, Cristol JP, Cavalier E, Bargnoux AS, Halimi JM, Froissart M, Piéroni L, Delanaye P; Société Française de Biologie Clinique (SFBC).

Clin Chim Acta. 2014 Jan 20;428:89-95. doi: 10.1016/j.cca.2013.11.002. Epub 2013 Nov 10.

23.

Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold.

Metzger M, Houillier P, Gauci C, Haymann JP, Flamant M, Thervet E, Boffa JJ, Vrtovsnik F, Froissart M, Stengel B, Ureña-Torres P; NephroTest Study Group.

J Clin Endocrinol Metab. 2013 Jul;98(7):2922-8. doi: 10.1210/jc.2013-1294. Epub 2013 Apr 30.

PMID:
23633202
24.

Performance of GFR estimating equations in African Europeans: basis for a lower race-ethnicity factor than in African Americans.

Flamant M, Vidal-Petiot E, Metzger M, Haymann JP, Letavernier E, Delatour V, Karras A, Thervet E, Boffa JJ, Houillier P, Stengel B, Vrtovsnik F, Froissart M; NephroTest Study Group.

Am J Kidney Dis. 2013 Jul;62(1):182-4. doi: 10.1053/j.ajkd.2013.03.015. Epub 2013 Apr 20. No abstract available.

PMID:
23608543
25.

Enzymatic but not compensated Jaffe methods reach the desirable specifications of NKDEP at normal levels of creatinine. Results of the French multicentric evaluation.

Boutten A, Bargnoux AS, Carlier MC, Delanaye P, Rozet E, Delatour V, Cavalier E, Hanser AM, Froissart M, Cristol JP, Piéroni L; Société Française de Biologie Clinique.

Clin Chim Acta. 2013 Apr 18;419:132-5. doi: 10.1016/j.cca.2013.01.021. Epub 2013 Feb 13.

PMID:
23415696
26.

Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease.

Karras A, Haymann JP, Bozec E, Metzger M, Jacquot C, Maruani G, Houillier P, Froissart M, Stengel B, Guardiola P, Laurent S, Boutouyrie P, Briet M; Nephro Test Study Group.

Hypertension. 2012 Dec;60(6):1451-7. doi: 10.1161/HYPERTENSIONAHA.112.197210. Epub 2012 Oct 22.

PMID:
23090769
27.

The sentinel node technique detects unexpected drainage pathways and allows nodal ultrastaging in early cervical cancer: insights from the multicenter prospective SENTICOL study.

Bats AS, Mathevet P, Buenerd A, Orliaguet I, Mery E, Zerdoud S, Le Frère-Belda MA, Froissart M, Querleu D, Martinez A, Leblanc E, Morice P, Daraï E, Marret H, Gillaizeau F, Lécuru F.

Ann Surg Oncol. 2013 Feb;20(2):413-22. doi: 10.1245/s10434-012-2597-7. Epub 2012 Aug 22.

PMID:
22911367
28.

Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study.

Helmer C, Stengel B, Metzger M, Froissart M, Massy ZA, Tzourio C, Berr C, Dartigues JF.

Neurology. 2011 Dec 6;77(23):2043-51. doi: 10.1212/WNL.0b013e31823b4765. Epub 2011 Nov 23.

PMID:
22116945
29.

Timing and determinants of erythropoietin deficiency in chronic kidney disease.

Mercadal L, Metzger M, Casadevall N, Haymann JP, Karras A, Boffa JJ, Flamant M, Vrtovsnik F, Stengel B, Froissart M; NephroTest Study Group.

Clin J Am Soc Nephrol. 2012 Jan;7(1):35-42. doi: 10.2215/CJN.04690511. Epub 2011 Nov 17.

30.

Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD.

Ureña-Torres P, Metzger M, Haymann JP, Karras A, Boffa JJ, Flamant M, Vrtovsnik F, Gauci C, Froissart M, Houillier P, Stengel B; NephroTest Study Group.

Am J Kidney Dis. 2011 Oct;58(4):544-53. doi: 10.1053/j.ajkd.2011.04.029. Epub 2011 Jul 31.

PMID:
21803465
31.

A multicentric evaluation of IDMS-traceable creatinine enzymatic assays.

Piéroni L, Delanaye P, Boutten A, Bargnoux AS, Rozet E, Delatour V, Carlier MC, Hanser AM, Cavalier E, Froissart M, Cristol JP; Société Française de Biologie Clinique.

Clin Chim Acta. 2011 Nov 20;412(23-24):2070-5. doi: 10.1016/j.cca.2011.07.012. Epub 2011 Jul 22.

32.

Mortality in chronic kidney disease and mineral metabolism.

Floege J, Kronenberg F, Froissart M.

JAMA. 2011 Jul 13;306(2):159; author reply 159-60. doi: 10.1001/jama.2011.948. No abstract available.

PMID:
21750291
33.

Epidemiology and prognostic significance of chronic kidney disease in the elderly--the Three-City prospective cohort study.

Stengel B, Metzger M, Froissart M, Rainfray M, Berr C, Tzourio C, Helmer C.

Nephrol Dial Transplant. 2011 Oct;26(10):3286-95. doi: 10.1093/ndt/gfr323. Epub 2011 Jun 15.

34.

Arterial remodeling associates with CKD progression.

Briet M, Collin C, Karras A, Laurent S, Bozec E, Jacquot C, Stengel B, Houillier P, Froissart M, Boutouyrie P; Nephrotest Study Group.

J Am Soc Nephrol. 2011 May;22(5):967-74. doi: 10.1681/ASN.2010080863. Epub 2011 Apr 14.

35.

[Recommendations for the selection and alignment techniques for the determination of creatinine].

Bargnoux AS, Boutten A, Cambillau M, Carlier MC, Cavalier E, Cristol JP, Hanser AM, Piéroni L, Delanaye P, Frimat L, Froissart M; Working group of the French Society of Clinical Chemistry and the French Society of Nephrology.

Ann Biol Clin (Paris). 2011 Jan-Feb;69(1):9-16. doi: 10.1684/abc.2010.0510. French.

36.

Long-term changes in arterial structure and function and left ventricular geometry after enzyme replacement therapy in patients affected with Fabry disease.

Collin C, Briet M, Tran TC, Beaussier H, Benistan K, Bensalah M, Mousseaux E, Froissart M, Bozec E, Laurent S, Boutouyrie P, Germain DP.

Eur J Prev Cardiol. 2012 Feb;19(1):43-54. doi: 10.1177/1741826710391118. Epub 2011 Mar 4.

PMID:
21450622
37.

Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based study.

Breton G, Froissart M, Janus N, Launay-Vacher V, Berr C, Tzourio C, Helmer C, Stengel B.

Nephrol Dial Transplant. 2011 Sep;26(9):2852-9. doi: 10.1093/ndt/gfq827. Epub 2011 Feb 3.

38.

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts.

Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, Jong PE, Coresh J; Chronic Kidney Disease Prognosis Consortium, Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, de Jong PE, Coresh J, El-Nahas M, Eckardt KU, Kasiske BL, Wright J, Appel L, Greene T, Levin A, Djurdjev O, Wheeler DC, Landray MJ, Townend JN, Emberson J, Clark LE, Macleod A, Marks A, Ali T, Fluck N, Prescott G, Smith DH, Weinstein JR, Johnson ES, Thorp ML, Wetzels JF, Blankestijn PJ, van Zuilen AD, Menon V, Sarnak M, Beck G, Kronenberg F, Kollerits B, Froissart M, Stengel B, Metzger M, Remuzzi G, Ruggenenti P, Perna A, Heerspink HJ, Brenner B, de Zeeuw D, Rossing P, Parving HH, Auguste P, Veldhuis K, Wang Y, Camarata L, Thomas B, Manley T.

Kidney Int. 2011 Jun;79(12):1331-40. doi: 10.1038/ki.2010.550. Epub 2011 Feb 2.

39.

Equations to estimate creatinine excretion rate: the CKD epidemiology collaboration.

Ix JH, Wassel CL, Stevens LA, Beck GJ, Froissart M, Navis G, Rodby R, Torres VE, Zhang YL, Greene T, Levey AS.

Clin J Am Soc Nephrol. 2011 Jan;6(1):184-91. doi: 10.2215/CJN.05030610. Epub 2010 Oct 21.

40.

How many measurements to make a decision?

Houillier P, Coste J, Froissart M.

Clin J Am Soc Nephrol. 2010 Jul;5(7):1161-2. doi: 10.2215/CJN.04440510. Epub 2010 Jun 17. No abstract available.

41.

Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2.

Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M, Hamm LL, Lewis JB, Mauer M, Navis GJ, Steffes MW, Eggers PW, Coresh J, Levey AS.

Am J Kidney Dis. 2010 Sep;56(3):486-95. doi: 10.1053/j.ajkd.2010.03.026. Epub 2010 Jun 16.

42.

A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia.

Macdougall IC, Rossert J, Casadevall N, Stead RB, Duliege AM, Froissart M, Eckardt KU.

N Engl J Med. 2009 Nov 5;361(19):1848-55. doi: 10.1056/NEJMoa074037.

43.

Age-independent association between arterial and bone remodeling in mild-to-moderate chronic kidney disease.

Briet M, Maruani G, Collin C, Bozec E, Gauci C, Boutouyrie P, Houillier P, Laurent S, Froissart M.

Nephrol Dial Transplant. 2010 Jan;25(1):191-7. doi: 10.1093/ndt/gfp373. Epub 2009 Aug 4.

PMID:
19654229
44.

Limitations of non-corrected and albumin-corrected total calcium concentrations in CKD patients.

Froissart M, Houillier P; Nephro Test Study Group.

Nephrol Dial Transplant. 2009 Jul;24(7):2291-2; author reply 2292-3. doi: 10.1093/ndt/gfp145. Epub 2009 Apr 6. No abstract available.

PMID:
19349292
45.

Factors other than glomerular filtration rate affect serum cystatin C levels.

Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS.

Kidney Int. 2009 Mar;75(6):652-60. doi: 10.1038/ki.2008.638. Epub 2008 Dec 31.

46.

Timing of onset of CKD-related metabolic complications.

Moranne O, Froissart M, Rossert J, Gauci C, Boffa JJ, Haymann JP, M'rad MB, Jacquot C, Houillier P, Stengel B, Fouqueray B; NephroTest Study Group.

J Am Soc Nephrol. 2009 Jan;20(1):164-71. doi: 10.1681/ASN.2008020159. Epub 2008 Nov 12.

47.

Cystatin C: current position and future prospects.

Séronie-Vivien S, Delanaye P, Piéroni L, Mariat C, Froissart M, Cristol JP; SFBC "Biology of renal function and renal failure" working group.

Clin Chem Lab Med. 2008;46(12):1664-86. doi: 10.1515/CCLM.2008.336. Review.

48.

Reproducibility of GFR measured by chromium-51-EDTA and iohexol.

Delanaye P, Cavalier E, Froissart M, Krzesinski JM.

Nephrol Dial Transplant. 2008 Dec;23(12):4077-8; author reply 4078. doi: 10.1093/ndt/gfn496. Epub 2008 Sep 4. No abstract available.

49.

Determination of lowest possible creatinine in living-donor kidney renal transplant recipients based on donor kidney function.

Sberro R, Zuber J, Froissart M, Canaud G, Prié D, Martinez F, Mamzer-Bruneel MF, Anglicheau D, Legendre C, Thervet E.

Transplantation. 2008 Aug 27;86(4):558-63. doi: 10.1097/TP.0b013e318181dfc7.

PMID:
18724226
50.

[Cystatin C: current step and future prospects].

Séronie-Vivien S, Delanaye P, Pieroni L, Mariat C, Froissart M, Cristol JP; Groupe de travail "Biologie des fonctions rénales et de l'insuffisance rénale" de la SFBC.

Ann Biol Clin (Paris). 2008 May-Jun;66(3):301-23. doi: 10.1684/abc.2008.0227. Review. French.

Supplemental Content

Loading ...
Support Center